Dissection of the LXXLL Nuclear Receptor-Coactivator Interaction Motif Using Combinatorial Peptide Libraries: Discovery of Peptide Antagonists of Estrogen Receptors α and β
- 1 December 1999
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 19 (12) , 8226-8239
- https://doi.org/10.1128/mcb.19.12.8226
Abstract
Recruitment of transcriptional coactivators following ligand activation is a critical step in nuclear receptor-mediated target gene expression. Upon binding an agonist, the receptor undergoes a conformational change which facilitates the formation of a specific coactivator binding pocket within the carboxyl terminus of the receptor. This permits the α-helical LXXLL motif within some coactivators to interact with the nuclear receptors. Until recently, the LXXLL motif was thought to function solely as a docking module; however, it now appears that sequences flanking the core motif may play a role in determining receptor selectivity. To address this issue, we used a combinatorial phage display approach to evaluate the role of flanking sequences in influencing these interactions. We sampled more than 108 variations of the core LXXLL motif with estradiol-activated estrogen receptor alpha (ERα) as a target and found three different classes of peptides. All of these peptides interacted with ERα in an agonist-dependent manner and disrupted ERα-mediated transcriptional activity when introduced into target cells. Using a series of ERα-mutants, we found that these three classes of peptides showed different interaction patterns from each other, suggesting that not all LXXLL motifs are the same and that receptor binding selectivity can be achieved by altering sequences flanking the LXXLL core motif. Most notable in this regard was the discovery of a peptide which, when overexpressed in cells, selectively disrupted ERβ- but not ERα-mediated reporter gene expression. This novel ERβ-specific antagonist may be useful in identifying and characterizing the ERβ-regulated process in estradiol-responsive cells. In conclusion, using a combinatorial approach to define cofactor-receptor interactions, we have clearly been able to demonstrate that not all LXXLL motifs are functionally equivalent, a finding which suggests that it may be possible to target receptor-LXXLL interactions to develop receptor-specific antagonists.Keywords
This publication has 69 references indexed in Scilit:
- Peptide Antagonists of the Human Estrogen ReceptorScience, 1999
- From peptides to drugs via phage displayDrug Discovery Today, 1998
- Enhancement of Estrogen Receptor Transcriptional Activity by the Coactivator GRIP-1 Highlights the Role of Activation Function 2 in Determining Estrogen Receptor PharmacologyJournal of Biological Chemistry, 1998
- Nuclear Receptor-Binding Sites of Coactivators Glucocorticoid Receptor Interacting Protein 1 (GRIP1) and Steroid Receptor Coactivator 1 (SRC-1): Multiple Motifs with Different Binding SpecificitiesMolecular Endocrinology, 1998
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- Nuclear receptor coactivators and corepressorsMolecular Endocrinology, 1996
- Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor SuperfamilyScience, 1995
- An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenitaNature, 1994
- Phosphorylated CREB binds specifically to the nuclear protein CBPNature, 1993